跳至主要内容
临床试验/NCT04431830
NCT04431830已完成不适用

Meaning-Centered Pain Coping Skills Training: A Randomized Pilot Trial for Patients With Advanced Cancer and Pain

Duke University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年2月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
2
主要终点
Feasibility as measured by attrition

研究概览

简要总结

This study is a randomized clinical trial of a psychosocial pain management intervention called, Meaning-Centered Pain Coping Skills Training (MCPC). Patients with advanced solid tumor cancer and at least moderate pain will be randomized to MCPC or a standard care control condition. Patient-reported outcomes will be assessed at baseline and 5- and 10-week follow-ups. The first aim of this study is to assess the feasibility of conducting a randomized clinical trial to test MCPC. The second aim is to characterize MCPC's effects on patient-reported outcomes of pain severity, pain interference, meaning in life, self-efficacy for pain management, and psychological distress. The third aim is to describe participants' experiences of MCPC using semi-structured qualitative interviews. The risk and safety issues in this trial are low and limited to those common to a psychosocial intervention (e.g., loss of confidentiality).

详细描述

Many patients with advanced cancer describe pain as their most feared and distressing symptom. In this population, higher pain levels often predict worse physical, emotional, and existential/spiritual well-being. Psychosocial interventions show promise for improving cancer-related pain; however, no interventions address existential concerns (e.g., a loss of meaning in life) that are common among those facing pain from advanced illness. To address this need, an intervention called Meaning-Centered Pain Coping Skills Training (MCPC) was developed. MCPC seeks to teach patients cognitive and behavioral skills for managing pain (e.g., guided imagery) in order to help them engage with what gives their life a sense of meaning, purpose, and significance.

This pilot study is being conducted to prepare for a large-scale clinical trial that will test the efficacy of MCPC for improving patients' pain and pain-related outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stage IV solid tumor cancer diagnosis; or stage III pancreatic or lung cancer diagnosis
  • At least moderate pain (worst pain in past week >/= 4 out of 10) at screening
  • Eastern Cooperative Oncology Group (ECOG) performance status </= 2 at screening
  • Ability to speak and read English

排除标准

  • Brain tumor diagnosis
  • Significant cognitive impairment
  • Untreated serious mental illness that would interfere with engagement in the interventions (e.g., schizophrenia)
  • Previous engagement in Pain Coping Skills Training or Meaning-Centered Psychotherapy
  • Enrollment in hospice

结局指标

主要结局

Feasibility as measured by attrition

时间窗: 5-week follow-up (immediately post-intervention)

Treatment feasibility will be evidenced by no more than 25% attrition by the 5-week follow-up.

Feasibility as measured by study accrual

时间窗: Baseline

Treatment feasibility will be evidenced by meeting study accrual (N = 60).

Feasibility as measured by adherence and assessment completion

时间窗: 5-week follow-up (immediately post-intervention)

Treatment feasibility will be evidenced by at least 75% of participants completing all four intervention sessions as well as the 5-week follow-up assessment.

次要结局

  • Change in meaning in life(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)
  • Change in anxiety(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)
  • Change in hopelessness(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)
  • Change in pain interference(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)
  • Change in self-efficacy for pain management(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)
  • Change in depressive symptoms(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)
  • Change in pain severity(Baseline, 5-week follow-up (immediately post-intervention), and 10-week follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验